Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of highly potent and selective Cdc25 protein phosphatases inhibitors from miniaturization click-chemistry-based combinatorial libraries

Published:2019-12 Issue: Volume:183 Page:111696
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Jing Lanlan^ORCID,Wu Gaochan,Hao Xia,Olotu Fisayo A.,Kang Dongwei,Chen Chin Ho,Lee Kuo-Hsiung,Soliman Mahmoud E.S.^ORCID,Liu Xinyong,Song Yuning,Zhan Peng^ORCID

Funder

National Natural Science Foundation of China (NSFC

Natural Science Foundation of Shandong Province

Young Scholars Program of Shandong University (YSPSDU

Fundamental Research Funds of Shandong University

Key research and development project of Shandong Province

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference52 articles.

1. Cell cycle regulation by the Cdc25 phosphatase family;Nilsson;Prog. Cell Cycle Res.,2000

2. Cdc25A phosphatase: combinatorial phosphorylation, ubiquitylation and proteolysis;Busino;Oncogene,2004

3. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle;Nigg;Bioessays : News Rev. Cell. Mol. Dev. Biol.,1995

4. CDC25 phosphatases as potential human oncogenes;Galaktionov;Science (New York, N.Y.),1995

5. Discovery and characterization of novel imidazopyridine derivative CHEQ-2 as a potent CDC25 inhibitor and promising anticancer drug candidate;Song;Eur. J. Med. Chem.,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization;European Journal of Medicinal Chemistry;2024-11

2. Design, Synthesis, and Efficacy of Novel Trojan Horse Compounds Targeting Metabolic Vulnerabilities in Prostate Cancer;2024-08-30

3. Natural product cell division cycle 25 (CDC25) inhibitors: A promising source for cancer drug discovery;Journal of the Indian Chemical Society;2024-08

4. Novel dual inhibitor targeting CDC25 and HDAC for treating triple-negative breast cancer;2024-07-24

5. Discovery of new inhibitors of Cdc25B phosphatases by molecular docking-based virtual screening;Journal of Molecular Structure;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3